This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Disease modifying therapy and the risk of hospitalization in patients with heart failure: A contemporary Medicaid cohort analysis

Fadia T. Shaya, Ian M. Breunig, and Mandeep R. Mehra


June 15, 2015
The objective of this study is o examine comorbidity and therapy use rates in a Medicaid population with heart failure (HF), evaluate hospitalization risk as a function of comorbidity and therapy use, and assess the impact of modification on costs to the Medicaid program. It is a historical prospective cohort study. Claims were from adult enrollees in Maryland Medicaid (managed care organization or fee-for-service) diagnosed with HF between 2005 and 2009.
North America